volum
number
august
natur
neurosci
p
e
r
p
e
c
v
e
f
c
u
n
n
e
u
r
u
n
e
n
e
r
c
n
multipl
sclerosi
ms
spontan
acquir
inflammatori
demyelin
diseas
human
cn
involv
complex
interact
two
intric
biolog
system
immun
system
cn
anim
model
critic
address
ms
pathogenesi
ms
model
origin
develop
serendipit
year
ago
immunemedi
toxic
viral
genet
model
demyelin
use
understand
manifold
aspect
ms
ms
treatment
evolv
part
anim
model
research
progress
envisag
larg
part
system
continu
refin
use
focus
question
whose
relev
establish
studi
human
diseas
ms
sporad
inflammatori
demyelin
diseas
human
cn
patholog
clinic
phenomena
ms
describ
first
half
nineteenth
centuri
carswel
cruveilhi
von
frerich
rokitanski
crucial
step
establish
clinicalpatholog
relationship
ms
therebi
character
diseas
distinct
entiti
attribut
charcot
latter
half
nineteenth
centuri
howev
person
diari
histor
work
push
back
descript
diseas
least
perhap
year
earlier
lucidli
summar
http
mssocietyiepag
historicaloverview
first
ms
grip
investig
continu
spur
research
effort
diseas
mainli
begin
person
late
earli
run
chronic
often
debilit
cours
carri
larg
burden
suffer
expens
approxim
million
affect
worldwid
disord
mani
year
explain
vagu
coincid
environment
factor
unexplain
influenc
occur
genet
suscept
background
lack
highli
effect
treatment
recent
year
seen
progress
front
genet
trait
underli
ms
suscept
larg
establish
genomewid
associ
studi
gwa
level
studi
show
convincingli
immun
factor
paramount
import
ms
share
genet
characterist
organspecif
inflammatori
disord
rheumatoid
arthriti
inflammatori
bowel
diseas
environment
factor
predispos
ms
mainli
low
vitamin
infect
epsteinbarr
viru
also
elucid
investig
children
ms
minor
whose
exist
make
outsiz
contribut
research
particularli
effect
valid
environment
risk
factor
diseas
occurr
therapeut
attack
ms
significantli
enrich
recent
year
permit
first
time
ration
algorithm
appli
firstlin
secondlin
medic
consid
anim
model
ms
first
question
must
one
tri
model
affect
individu
natur
histori
untreat
ms
follow
reason
predict
cours
patient
women
show
initi
evid
diseas
age
sharp
peak
age
present
intermitt
episod
neurolog
dysfunct
term
attack
relaps
common
earli
symptom
includ
blur
vision
sensori
disturb
either
tingl
loss
sensat
motor
impair
symptom
typic
regress
often
extent
neurolog
function
return
normal
attack
occur
averag
everi
year
mri
brain
scan
show
abnorm
signal
periventricular
posterior
fossa
spinal
cord
white
matter
often
accompani
evid
transient
bloodbrain
barrier
bbb
disrupt
affect
individu
almost
alway
previou
good
health
although
initi
episod
follow
common
mild
infect
upper
respiratori
viral
ill
phase
diseas
term
relapsingremit
ms
last
year
commonli
follow
secondari
progress
ms
neurolog
function
slowli
worsen
mani
fewer
attack
phase
ms
predict
usual
culmin
least
loss
abil
walk
independ
cane
walker
wheelchair
forese
whether
function
includ
use
arm
cognit
abil
similarli
affect
phase
ms
somewhat
arbitrari
identif
individu
patient
tend
equivoc
use
persist
one
scheme
phase
ms
correl
age
propos
pathogen
mechan
treatment
respons
shown
tabl
howev
ms
notori
unpredict
small
perhap
case
exhibit
substanti
impact
diseas
condit
term
benign
ms
smallerstil
group
show
fulmin
ms
die
within
year
ill
onset
perhap
case
manifest
attack
present
progress
phase
diseas
primari
progress
ms
evid
exist
primari
progress
ms
although
phenotyp
distinct
pathogenet
similar
relapsingremit
secondari
progress
ms
level
tissu
patholog
ms
attack
character
infiltr
cn
parenchyma
bloodderiv
cell
mainli
lymphocyt
monocyt
along
compromis
function
bbb
cn
axon
demyelin
like
activ
process
may
involv
action
macrophag
may
deriv
either
microglia
monocyt
target
attack
myelin
occur
involv
complex
interact
two
intric
biolog
system
immun
system
cn
anim
model
critic
address
ms
pathogenesi
ms
model
origin
develop
serendipit
year
ago
immunemedi
toxic
viral
genet
model
demyelin
use
understand
manifold
aspect
ms
ms
treatment
evolv
part
anim
model
research
progress
envisag
larg
part
system
continu
refin
use
focus
question
whose
relev
establish
studi
human
diseas
ms
sporad
inflammatori
demyelin
diseas
human
cn
patholog
clinic
phenomena
ms
describ
first
half
nineteenth
centuri
carswel
cruveilhi
von
frerich
rokitanski
crucial
step
establish
clinicalpatholog
relationship
ms
therebi
character
diseas
distinct
entiti
attribut
charcot
latter
half
nineteenth
centuri
howev
person
diari
histor
work
push
back
descript
diseas
least
perhap
year
earlier
lucidli
summar
http
mssocietyiepag
historicaloverview
first
ms
grip
investig
continu
spur
research
effort
diseas
mainli
begin
person
late
earli
run
chronic
often
debilit
cours
carri
larg
burden
suffer
expens
approxim
million
affect
worldwid
disord
mani
year
explain
vagu
coincid
environment
factor
unexplain
influenc
occur
genet
suscept
background
lack
highli
effect
treatment
recent
year
seen
progress
front
genet
trait
underli
ms
suscept
larg
establish
genomewid
associ
studi
gwa
level
studi
show
convincingli
immun
factor
paramount
import
ms
share
genet
characterist
organspecif
inflammatori
disord
rheumatoid
arthriti
inflammatori
bowel
diseas
environment
factor
predispos
ms
mainli
low
vitamin
infect
epsteinbarr
viru
also
elucid
investig
children
ms
minor
whose
exist
make
outsiz
contribut
research
particularli
effect
valid
environment
risk
factor
diseas
occurr
therapeut
attack
ms
significantli
enrich
recent
year
permit
first
time
ration
algorithm
appli
firstlin
secondlin
medic
consid
anim
model
ms
first
question
must
one
tri
model
affect
individu
natur
histori
untreat
ms
follow
reason
predict
cours
patient
women
show
initi
evid
diseas
age
sharp
peak
age
present
intermitt
episod
neurolog
dysfunct
term
attack
relaps
common
earli
symptom
includ
blur
vision
sensori
disturb
either
tingl
loss
sensat
motor
impair
symptom
typic
regress
often
extent
neurolog
function
return
normal
attack
occur
averag
everi
year
mri
brain
scan
show
abnorm
signal
periventricular
posterior
fossa
spinal
cord
white
matter
often
accompani
evid
transient
bloodbrain
barrier
bbb
disrupt
affect
individu
almost
alway
previou
good
health
although
initi
episod
follow
common
mild
infect
upper
respiratori
viral
ill
phase
diseas
term
relapsingremit
ms
last
year
commonli
follow
secondari
progress
ms
neurolog
function
slowli
worsen
mani
fewer
attack
phase
ms
predict
usual
culmin
least
loss
abil
walk
independ
cane
walker
wheelchair
forese
whether
function
includ
use
arm
cognit
abil
similarli
affect
phase
ms
somewhat
arbitrari
identif
individu
patient
tend
equivoc
use
persist
one
scheme
phase
ms
correl
age
propos
pathogen
mechan
treatment
respons
shown
tabl
howev
ms
notori
unpredict
small
perhap
case
exhibit
substanti
impact
diseas
condit
term
benign
ms
smallerstil
group
show
fulmin
ms
die
within
year
ill
onset
perhap
case
manifest
attack
present
progress
phase
diseas
primari
progress
ms
evid
exist
primari
progress
ms
although
phenotyp
distinct
pathogenet
similar
relapsingremit
secondari
progress
ms
level
tissu
patholog
ms
attack
character
infiltr
cn
parenchyma
bloodderiv
cell
mainli
lymphocyt
monocyt
along
compromis
function
bbb
cn
axon
demyelin
like
activ
process
may
involv
action
macrophag
may
deriv
either
microglia
monocyt
target
attack
myelin
occur
uncertain
process
possibl
includ
myelinspecif
antibodi
inflammatori
cytokin
produc
cell
macrophag
activ
parenchym
element
astrocyt
microglia
cytokin
environ
includ
innat
factor
interleukin
il
well
special
adaptiveimmun
cytokin
interferon
ifn
among
other
injuri
reactiv
oxygen
nitrogen
speci
present
along
prostaglandin
vasoact
factor
chemokin
includ
also
found
sever
lesion
axon
transect
occur
possibl
bystand
effect
reflect
loss
protect
myelin
toxic
environ
acut
lesion
show
rel
largescal
oligodendrocyt
loss
along
indic
hypox
tissu
damag
alter
pattern
inflamm
lesion
term
pattern
iii
investig
character
may
repres
distinct
form
diseas
pathogenesi
cerebr
cortex
also
involv
earli
stage
ms
show
inflammatori
demyelin
similar
observ
white
matter
lesion
resolv
myelin
repair
often
occur
remyelin
neuroprotect
demyelin
axon
show
decreas
longterm
viabil
furthermor
remyelin
character
autopsi
appear
much
robust
case
other
possibl
provid
insight
highli
variabl
outcom
ms
individu
case
experiment
autoimmun
encephalomyel
forerunn
ms
uniqu
human
far
known
asid
theiler
murin
encephalomyel
viru
tmev
infect
mice
see
spontan
diseas
speci
resembl
ms
suffici
provid
translat
insight
disord
experiment
autoimmun
encephalomyel
eae
famili
diseas
model
wide
appli
mean
studi
ms
research
bench
eae
discov
year
ago
effort
clarifi
origin
neuroparalyt
accid
fear
common
complic
vaccin
rabi
viru
vaccin
inoculum
prepar
tissu
contain
neural
element
tissu
patholog
fatal
case
resembl
rabi
infect
therefor
one
simpl
question
whether
rabi
viru
requir
syndrom
issu
address
inject
nonhuman
primat
tissu
homogen
similar
use
rabi
vaccin
clear
find
acut
enceph
could
produc
immun
refin
eae
proceed
steadili
sinc
eae
paper
list
pubm
march
research
mileston
includ
show
histopatholog
eae
resembl
ms
white
matter
efficaci
gray
induc
diseas
myelin
activ
principl
white
matter
myelin
basic
protein
mbp
first
identifi
antigen
compon
follow
mani
other
includ
myelin
proteolipid
protein
plp
myelin
oligodendrogli
glycoprotein
mog
cell
rather
serum
found
transfer
diseas
naiv
host
lead
find
cell
clone
could
mediat
paralyt
inflamm
clone
react
short
peptid
myelin
protein
relaps
form
eae
could
readili
produc
mous
strain
promin
sjlj
ref
time
eae
research
move
nonhuman
primat
larger
rodent
rat
guinea
pig
mice
take
advantag
genet
resourc
transgen
knockout
use
mice
eae
experi
entail
sacrif
neurobehavior
neuropatholog
complex
well
restrict
imag
studi
gaug
comparison
research
done
use
marmoset
exampl
studi
present
done
use
mice
diseas
induc
immun
mog
peptid
repres
residu
emulsifi
freund
adjuv
supplement
mycobacterium
tuberculosi
extract
mice
also
inject
pertussi
toxin
day
immun
day
thereaft
protocol
use
work
reproduc
allow
one
take
advantag
wealth
genet
resourc
background
introduc
offset
array
limit
exampl
inform
lost
model
eae
monophas
without
relaps
cell
compon
predominantli
spinal
cord
affect
proport
brain
unlik
ms
common
form
eae
although
except
eae
contribut
enorm
understand
autoimmun
neuroinflamm
cytokin
biolog
immunogenet
sure
chang
cours
ms
research
one
major
ms
treatment
came
directli
mechanismbas
fashion
eae
research
treatment
glatiram
acet
mixtur
oligomer
peptid
first
studi
eae
applic
diseas
treatment
wander
fairli
far
initi
rational
develop
part
eae
proven
poorli
predict
treatment
success
ms
particularli
concern
p
e
r
p
e
c
v
e
npg
p
e
r
p
e
c
v
e
manipul
inflammatori
cytokin
tnf
reason
underli
misadventur
remain
investig
mean
clear
cytokin
central
function
immun
inflamm
perform
differ
ms
eae
plausibl
human
mous
eae
model
help
clarifi
issu
eae
nevertheless
unequivoc
valu
model
inflammatori
aspect
ms
regard
essenti
tool
armamentarium
ms
research
everi
reduct
system
use
scienc
critic
mind
implement
wide
recogn
util
eae
restrict
virtu
induc
administr
power
immun
adjuv
percept
led
develop
spontan
eae
model
vari
reason
includ
highli
engin
model
wide
appli
despit
yield
fascin
insight
eae
silent
respons
mani
urgent
question
pertin
understand
treat
ms
eae
provid
insight
ms
progress
viabil
persist
demyelin
axon
eae
tissu
reduc
littl
progress
made
understand
limit
still
mice
eae
exhibit
ongo
function
deterior
patient
ms
tissu
chang
correl
behavior
deficit
use
mice
sacrific
opportun
studi
relaps
remyelin
well
studi
eae
lesion
occur
stochast
regard
time
local
wellperform
mechanist
studi
myelin
damag
eae
tissu
vanishingli
rare
investig
use
eae
examin
potenti
benefit
treatment
neuron
oligodendrogli
growth
surviv
factor
disappoint
prototyp
find
mani
factor
regard
neurobiolog
exert
remark
strong
effect
immun
inflammatori
cell
make
result
treatment
uninterpret
eae
mainli
diseas
subpial
spinal
cord
white
matter
wherea
ms
mainli
brain
diseas
promin
demyelin
cerebr
cerebellar
cortex
involv
cortex
eae
difficult
discern
therefor
well
studi
form
eae
gener
immun
regimen
elicit
cell
respons
role
cell
predomin
ms
lesion
show
clonal
expans
difficult
captur
use
convent
eae
model
eae
studi
product
concern
role
b
cell
ms
despit
recent
clinicaltri
data
demonstr
import
summari
eae
loom
larg
histori
ms
research
probabl
repres
oldest
anim
model
neurolog
diseas
question
relat
function
immun
inflammatori
compon
autoimmun
cn
diseas
eae
provid
remark
flexibl
potent
rapid
platform
research
predict
valu
treatment
efficaci
poor
howev
perform
best
ask
mechanist
research
question
ms
model
challeng
hypothes
studi
patient
materi
perform
clinic
trial
repres
critic
test
virusinduc
demyelin
diseas
viral
infect
cn
induc
demyelin
mice
usual
aftermath
bout
resolv
enceph
best
studi
picornaviru
tmev
certain
strain
coronaviru
mous
hepat
viru
mhv
agent
incis
dissect
level
viral
host
genet
identifi
mechan
viral
clearanc
control
well
demyelin
tmev
product
clarifi
determin
delay
induc
autoimmun
wake
immun
respons
neurotrop
viru
tmev
research
also
provid
insight
origin
behavior
sign
follow
demyelin
murin
cn
pathogenesi
tmevinduc
demyelin
probabl
differ
ms
persist
viral
infect
cn
demonstr
mhv
provid
model
viral
infect
cn
clear
control
remark
welldefin
mechan
notabl
mhv
enceph
carri
sequela
inflammatori
demyelin
absenc
detect
pathogen
gene
express
elucid
appar
hit
run
demyelin
event
may
hold
lesson
understand
ms
toxic
model
demyelin
remyelin
understand
remyelin
hold
consider
promis
amelior
preclud
progress
ms
yet
address
use
eae
administr
toxin
overcom
concern
time
local
demyelin
enabl
studi
remyelin
enhanc
remyelin
deem
crucial
neuroprotect
ms
therefor
major
line
defens
progress
diseas
toxininduc
ms
model
among
signific
tool
translat
research
two
model
use
extens
one
copper
chelat
cuprizon
chow
fed
mice
suscept
strain
week
cuprizon
caus
dysfunct
mitochondri
complex
iv
select
toxic
oligodendrocyt
among
cn
cell
oligodendrocyt
corpu
callosum
hippocampu
cuprizonef
mice
undergo
apoptosi
week
treatment
cuprizon
discontinu
remyelin
ensu
model
provid
insight
determin
oligodendrocyt
cell
death
extens
model
use
examin
mechan
remyelin
frequent
surpris
result
cuprizon
lesion
unlik
eae
lesion
bear
resembl
pattern
iii
ms
cuprizoneinduc
tissu
injuri
demyelin
remyelin
coincid
lesion
evolv
attribut
model
regard
strength
ms
lesion
show
similar
featur
damag
repair
howev
dynam
complex
also
pose
hurdl
interpret
respons
oligodendrocyt
progenitor
stem
cell
progeni
cellular
mediat
remyelin
microinject
lysophosphatidylcholin
ethidium
bromid
use
less
frequent
white
matter
tract
caus
prompt
demyelin
follow
remyelin
model
use
product
examin
cellular
molecular
determin
remyelin
salient
strength
directli
appli
toxin
lie
isol
demyelin
remyelin
discret
event
spatiotempor
predict
weak
inher
absenc
ongo
immun
activ
seen
ms
great
promis
use
injectionbas
cuprizon
toxic
model
identifi
strategi
enhanc
remyelin
furthermor
cuprizon
model
like
adapt
studi
hippocamp
demyelin
identifi
mechan
degener
surviv
persist
demyelin
axon
one
seen
cours
cuprizon
featur
urgent
expand
treatment
option
ms
patient
recent
genet
mean
induc
oligodendrocyt
apoptosi
appli
studi
demyelin
remyelin
approach
npg
p
e
r
p
e
c
v
e
p
e
r
p
e
c
v
e
involv
engin
suicid
gene
condit
diphtheria
toxin
receptor
select
express
oligodendrocyt
follow
administr
induc
cell
death
diphtheria
toxin
applic
approach
remain
earli
day
definit
insight
forthcom
clearli
fascin
import
demyelin
caus
induc
oligodendrocyt
cell
death
could
prime
immun
system
recogn
myelin
antigen
ms
research
divers
tool
kit
studi
inflamm
immun
demyelin
remyelin
therapeut
landscap
ms
patient
much
richer
effort
howev
field
lack
focus
translat
diseas
model
progress
ms
largest
unmet
need
difficult
research
problem
patient
physician
balanc
concern
import
note
pathogen
process
list
inflamm
immun
demyelin
remyelin
pertin
relaps
inflammatori
ms
progress
neurodegen
ms
furthermor
aspect
cn
age
also
relev
progress
ms
strikingli
age
depend
given
consider
make
sens
investig
explicit
clinic
aspect
mechanist
hypothes
model
experiment
data
present
approach
would
enabl
better
understand
reader
intent
research
studi
ultim
progress
could
promot
effici
integr
result
come
mani
distinct
approach
effort
understand
diseas
integr
complex
nervou
immun
systemsargu
two
intric
structur
know
